/Eli%20Lilly%20and%20Co_%20by%20Sergio%20Photone%20via%20Shutterstock.jpg)
Eli Lilly and Company (LLY), headquartered in Indianapolis, Indiana, is a major American pharmaceutical company. Established in 1876, the firm has a rich legacy of innovation and is currently valued at a market capitalization of $728.8 billion.
Shares of the drugmaker have underperformed the broader market over the past 52 weeks. LLY shares have decreased 1.2% over this time frame, while the broader S&P 500 Index ($SPX) has gained 21.5%. Moreover, in 2025, LLY stock has dropped marginally, compared to $SPX's 7.1% YTD rise.